This course discusses sarcopenia screening in patients with type 2 diabetes that appear to be at increased risk for and may develop cardiovascular disease earlier in life than people with type 2 diabetes alone.
The post CME/CE: Sarcopenia Screening May Reduce CVD Risk in Patients With Type 2 Diabetes first appeared on Physician's Weekly.